A Multicenter Study of Artificial Intelligence Model for Fetal Congenital Heart Disease
Beijing Anzhen Hospital
1 other identifier
observational
10,000
1 country
1
Brief Summary
This study addresses congenital heart disease in fetuses, a specific birth defect, by collaborating with multicenter medical institutions across China. It prospectively collects echocardiographic screening, diagnostic images, and structured parameter data from both normal and abnormal fetuses. Cases are followed up, and artificial intelligence (AI) models are developed to extract fetal heart echocardiographic image features and analyze the data. This process allows for the analysis of the AI models' accuracy, sensitivity, and specificity, and verifies the application value of AI models in fetal heart echocardiographic screening and diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 20, 2025
CompletedFirst Posted
Study publicly available on registry
January 28, 2025
CompletedStudy Start
First participant enrolled
February 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
ExpectedJanuary 28, 2025
January 1, 2025
1 year
January 20, 2025
January 26, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Diagnostic efficiency of AI model for fetal CHD
From enrollment to diagnostic verification, the evaluation period should not exceed 12 month.
Eligibility Criteria
The study population was from 20 multi-center medical institutions in China, and pregnant women who underwent fetal echocardiography between 16 and 40 weeks of gestation.
You may qualify if:
- Single or multiple pregnancy;
- Gestational age 16-40 weeks;
- Fetal echocardiographic images are clear and complete;
- Clinical data are complete and detailed;
- Sign informed consent and be able to cooperate with follow-up
You may not qualify if:
- Fetal echocardiographic images are incomplete or of poor quality that cannot be used for research;
- Refusal or loss of follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Anzhen Hospital affiliated to Capital Medical University
Beijing, Beijing Municipality, 100010, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 20, 2025
First Posted
January 28, 2025
Study Start
February 1, 2025
Primary Completion
February 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
January 28, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL